135 related articles for article (PubMed ID: 11248363)
1. Anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl] x guanine (A-5021) in vitro and in vivo.
Neyts J; Naesens L; Ying C; De Bolle L; De Clercq E
Antiviral Res; 2001 Feb; 49(2):115-20. PubMed ID: 11248363
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]- guanine (A-5021) in mice.
Iwayama S; Ohmura Y; Suzuki K; Ono N; Nakazawa H; Aoki M; Tanabe I; Sekiyama T; Tsuji T; Okunishi M; Yamanishi K; Nishiyama Y
Antiviral Res; 1999 Jun; 42(2):139-48. PubMed ID: 10389656
[TBL] [Abstract][Full Text] [Related]
3. The anti-herpesvirus activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)-cycloprop-1'-yl]methyl]guanine is markedly potentiated by the immunosuppressive agent mycophenolate mofetil.
Neyts J; De Clercq E
Antiviral Res; 2001 Feb; 49(2):121-7. PubMed ID: 11248364
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the antiviral activity of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) against equine herpesvirus type 1 in cell monolayers and equine nasal mucosal explants.
Glorieux S; Vandekerckhove AP; Goris N; Yang XY; Steukers L; Van de Walle GR; Croubels S; Neyts J; Nauwynck HJ
Antiviral Res; 2012 Feb; 93(2):234-238. PubMed ID: 22178244
[TBL] [Abstract][Full Text] [Related]
6. Antiherpesvirus activities of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine (A-5021) in cell culture.
Iwayama S; Ono N; Ohmura Y; Suzuki K; Aoki M; Nakazawa H; Oikawa M; Kato T; Okunishi M; Nishiyama Y; Yamanishi K
Antimicrob Agents Chemother; 1998 Jul; 42(7):1666-70. PubMed ID: 9661001
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiviral activity of novel acyclic nucleosides: discovery of a cyclopropyl nucleoside with potent inhibitory activity against herpesviruses.
Sekiyama T; Hatsuya S; Tanaka Y; Uchiyama M; Ono N; Iwayama S; Oikawa M; Suzuki K; Okunishi M; Tsuji T
J Med Chem; 1998 Apr; 41(8):1284-98. PubMed ID: 9548818
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-VZV activity of 6-heteroaryl derivatives of tricyclic acyclovir and 9-{[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl}guanine analogues.
Ostrowski T; Golankiewicz B; De Clercq E; Andrei G; Snoeck R
Eur J Med Chem; 2009 Aug; 44(8):3313-7. PubMed ID: 19339082
[TBL] [Abstract][Full Text] [Related]
9. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of 9-[[(ethoxyhydroxyphosphinyl)-methoxy]methoxy] guanine against cytomegalovirus and herpes simplex virus.
Kim HT; Kim DK; Kim YW; Kim KH; Sugiyama Y; Kikuchi M
Antiviral Res; 1995 Nov; 28(3):243-51. PubMed ID: 8629816
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antiviral activity of novel anti-VZV 5-substituted uracil nucleosides with a cyclopropane sugar moiety.
Onishi T; Mukai C; Nakagawa R; Sekiyama T; Aoki M; Suzuki K; Nakazawa H; Ono N; Ohmura Y; Iwayama S; Okunishi M; Tsuji T
J Med Chem; 2000 Jan; 43(2):278-82. PubMed ID: 10649983
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of methylenecyclopropane analogs of nucleosides against herpesvirus replication in vitro.
Kushner NL; Williams SL; Hartline CB; Harden EA; Bidanset DJ; Chen X; Zemlicka J; Kern ER
Nucleosides Nucleotides Nucleic Acids; 2003 Dec; 22(12):2105-19. PubMed ID: 14714760
[TBL] [Abstract][Full Text] [Related]
13. The antiherpesvirus activity of H2G [(R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine] is markedly enhanced by the novel immunosuppressive agent mycophenolate mofetil.
Neyts J; Andrei G; De Clercq E
Antimicrob Agents Chemother; 1998 Dec; 42(12):3285-9. PubMed ID: 9835529
[TBL] [Abstract][Full Text] [Related]
14. (+-)-(1 alpha,2 beta,3 alpha)-9-[2,3-bis(hydroxymethyl)-cyclobutyl] guanine [(+-)-BHCG or SQ 33,054]: a potent and selective inhibitor of herpesviruses.
Field AK; Tuomari AV; McGeever-Rubin B; Terry BJ; Mazina KE; Haffey ML; Hagen ME; Clark JM; Braitman A; Slusarchyk WA
Antiviral Res; 1990 Jan; 13(1):41-52. PubMed ID: 2159261
[TBL] [Abstract][Full Text] [Related]
15. [Antiviral activity of the organic germanium complex with aciclovir against herpes simplex virus (Herpesviridae: Alphaherpesvirinae: Simplexvirus: Human alphaherpesvirus 1/2) in the in vitro and in vivo systems].
Alimbarova LM; Ambrosov IV; Matelo SK; Barinsky IF
Vopr Virusol; 2021 Nov; 66(5):368-382. PubMed ID: 34738452
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of tricyclic analogues of 9-[[cis-1',2'-bis(hydroxymethyl)cycloprop-1'-yl]methyl]guanine.
Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
Bioorg Med Chem; 2006 May; 14(10):3535-42. PubMed ID: 16458009
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo antiherpetic effects of (1R,2R)-1-(5'-methylful-3'-yl)propane-1,2,3-triol.
Sasaki K; Hayashi K; Matsuya Y; Sugimoto K; Lee JB; Kurosaki F; Hayashi T
J Nat Med; 2016 Apr; 70(2):217-24. PubMed ID: 26763002
[TBL] [Abstract][Full Text] [Related]
18. Broad-spectrum antiviral activity of the acyclic guanosine phosphonate (R,S)-HPMPG.
Terry BJ; Mazina KE; Tuomari AV; Haffey ML; Hagen M; Feldman A; Slusarchyk WA; Young MG; Zahler R; Field AK
Antiviral Res; 1988 Dec; 10(4-5):235-51. PubMed ID: 2852486
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of A-73209, a potent orally active agent against VZV and HSV infections.
Alder J; Mitten M; Norbeck D; Marsh K; Kern ER; Clement J
Antiviral Res; 1994 Feb; 23(2):93-105. PubMed ID: 8147583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
